tiprankstipranks

Physiomics Updates Stakeholders with Interim Results Presentation

Story Highlights
Physiomics Updates Stakeholders with Interim Results Presentation

Don’t Miss TipRanks’ Half-Year Sale

Physiomics ( (GB:PYC) ) has shared an update.

Physiomics plc has updated its website with a recent presentation and Q&A session from its Interim Results meeting, accessible via their website. This update aims to provide stakeholders with insights into the company’s current operations and strategic direction, potentially impacting its market positioning and stakeholder engagement.

More about Physiomics

Physiomics plc is a leading company in mathematical modelling, data science, and biostatistics, focusing on the development of new therapeutics and personalized medicine solutions. The company aids biotech and pharma firms in optimizing drug development by leveraging expertise in Modelling & Simulation, Biostatistics, Data Science, and Bioinformatics. Their proprietary Virtual Tumour technology has been instrumental in over 100 commercial projects, working with clients such as Merck KGaA, Astellas, and Bicycle Therapeutics.

YTD Price Performance: -44.67%

Average Trading Volume: 4,954,080

Technical Sentiment Consensus Rating: Buy

Current Market Cap: £1.26M

Find detailed analytics on PYC stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1